Safety of influenza vaccination during pregnancy: A review of subsequent maternal obstetric events and findings from two recent cohort studies

Vaccine

Volumn 32, Issue 26, 2014, Pages 3122-3127

  Naleway, Allison L ^a   Irving, Stephanie A ^a   Henninger, Michelle L ^a   Li, De Kun ^b   Shifflett, Pat ^c   Ball, Sarah ^c   Williams, Jennifer L ^d   Cragan, Janet ^d   Gee, Julianne ^d   Thompson, Mark G ^d   Naleway, Allison ^e   Henninger, Michelle ^e   Crane, Brad ^e   Irving, Stephanie ^e   Donahue, James ^e   Kieke, Burney ^e   Cole, Deanna ^e   Weintraub, Eric ^e   Kauffman, Tia ^e   Bulkley, Joanna ^e   Kurosky, Samantha ^e   Siegel, Nancy ^e   Shiffiett, Pat ^e   Bozeman, Sam ^e   Ferber, Jeanette ^e   Odouli, Roxana ^e   Avalos, Lyndsay ^e   Thompson, Mark ^e   Williams, Jennifer ^e   Sokolow, Leslie ^e   Reynolds, Sue ^e   Shay, David ^e   more..

^a CENTER FOR HEALTH RESEARCH   (United States)

^b DIVISION OF RESEARCH   (United States)

^c ABT ASSOCIATES   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e NONE

Author keywords

Influenza vaccine; Obstetric outcomes; Pregnancy; Safety

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; CHORIOAMNIONITIS; COHORT ANALYSIS; DELIVERY; DRUG SAFETY; ECLAMPSIA; FOLLOW UP; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MATERNAL HYPERTENSION; OBSERVATIONAL STUDY; OBSTETRICS; PANDEMIC INFLUENZA; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; SEASONAL INFLUENZA; STILLBIRTH; UNITED STATES;

INFLUENZA VACCINE; OBSTETRIC OUTCOMES; PREGNANCY; SAFETY;

CHORIOAMNIONITIS; DIABETES, GESTATIONAL; ECLAMPSIA; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFLUENZA VACCINES; INFLUENZA, HUMAN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; VACCINATION; VACCINES, INACTIVATED;

EID: 84900414057     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.021     Document Type: Review

References (41)

1. Mak T.K., Mangtani P., Leese J., Watson J.M., Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis 2008, 8(1):44-52.
2. Tamma P.D., Ault K.A., del R.C., Steinhoff M.C., Halsey N.A., Omer S.B. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2009, 201(6):547-552.
3. Munoz F.M. Safety of influenza vaccines in pregnant women. Am J Obstet Gynecol 2012, 207(3 (Suppl.)):S33-S37.
4. Centers for Disease Control and Prevention. Prevention and Control of Seasonal Influenza with Vaccines. Recommendations of the Advisory Committee on Immunization Practices - United States, 2013-2014. MMWR Recomm Rep 2013;62(RR-07):1-43.
5. ACOG Committee Opinion No. 468: Influenza vaccination during pregnancy. Obstet Gynecol 2010;116(4):1006-07.
6. Naleway A.L., Smith W.J., Mullooly J.P. Delivering influenza vaccine to pregnant women. Epidemiol Rev 2006, 28:47-53.
7. Centers for Disease Control and Prevention. Influenza vaccination coverage among pregnant women - United States, 2012-13 influenza season. MMWR 2013;62(38):787-92.
8. Henninger M., Crane B., Naleway A. Trends in influenza vaccine coverage in pregnant women, 2008 to 2012. Perm J 2013, 17(2):31-36.
9. Healthy People 2020 objectives for influenza vaccination among pregnant women. Web site 2012. Available from: http://healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=23.
10. Henninger M., Naleway A., Crane B., Donahue J., Irving S. Predictors of seasonal influenza vaccination during pregnancy. Obstet Gynecol 2013, 121(4):741-749.
11. Omer S.B., Goodman D., Steinhoff M.C., Rochat R., Klugman K.P., Stoll B.J., et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med 2011, 8(5):e1000441.
12. Hauth J.C., Ewell M.G., Levine R.J., Esterlitz J.R., Sibai B., Curet L.B., et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol 2000, 95(1):24-28.
13. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183(1):s1-s22.
14. Fang J., Madhaven S., Alderman M.H. The influence of maternal hypertension on low birth weight: differences among ethnic populations. Ethn Dis 1999, 9(3):369-376.
15. Villar J., Carroli G., Wojdyla D., Abalos E., Giordano D., Ba'aqeel H., et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?. Am J Obstet Gynecol 2006, 194(4):921-931.
16. Lawler J., Osman M., Shelton J.A., Yeh J. Population-based analysis of hypertensive disorders in pregnancy. Hypertens Pregnancy 2007, 26(1):67-76.
17. Baraban E., McCoy L., Simon P. Increasing prevalence of gestational diabetes and pregnancy-related hypertension in Los Angeles County, California, 1991-2003. Prev Chronic Dis 2008, 5(3):A77.
18. Xiong X., Saunders L.D., Wang F.L., Demianczuk N.N. Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Int J Gynaecol Obstet 2001, 75(3):221-228.
19. Naylor C., Sermer M., Chen E., Sykora K. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style?. JAMA 1996, 275(15):1165-1170.
20. Magee M., Walden C.E., Benedetti T.J., Knopp R.H. Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity. JAMA 1993, 269(5):609-615.
21. Dabelea D., Hanson R.L., Lindsay R.S., Pettitt D.J., Imperatore G., Gabir M.M., et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 2000, 49(12):2208-2211.
22. Silverman B.L., Rizzo T.A., Cho N.H., Metzger B.E. Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center. Diabetes Care 1998, 21(Suppl. 2):B142-B149.
23. Engelgau M.M., Herman W.H., Smith P.J., German R.R., Aubert R.E. The epidemiology of diabetes and pregnancy in the U.S., 1988. Diabetes Care 1995, 18(7):1029-1033.
24. Ferrara A., Kahn H.S., Queensberry C.P., Riley C., Hedderson M.M. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000. Obstet Gynecol 2004, 103(3):526-533.
25. Thorpe L.E., Berger D., Ellis J.A., Bettegowda V.R., Brown G., Matte T., et al. Trends and racial/ethnic disparities in gestational diabetes among pregnant women in New York City, 1990-2001. Am J Public Health 2005, 95(9):1536-1539.
26. Getahun D., Strickland D., Zeiger R.S. EFfect of chorioamnionitis on early childhood asthma. Arch Pediatr Adolesc Med 2010, 164(2):187-192.
27. Nasef N., Shabaan A., Schurr P., Iaboni D., Choudhury J., Church P., et al. Effect of clinical and histological chorioamnionitis on the outcome of preterm infants. Am J Perinatol 2013, 30(01):59-68.
28. Christian L.M., Iams J.D., Porter K., Glaser R. Inflammatory responses to trivalent influenza virus vaccine among pregnant women. Vaccine 2011, 29(48):8982-8987.
29. Moro P.L., Broder K., Zheteyeva Y., Walton K., Rohan P., Sutherland A., et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol 2011, 204(2):146-147.
30. Moro P.L., Broder K., Zheteyeva Y., Revzina N., Tepper N., Kissin D., et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol 2011, 205(5):473-479.
31. Huang W.T., Chen W.C., Teng H.J., Huang W.I., Huang Y.W., Hsu C.W., et al. Adverse events following pandemic A (H1N1) 2009 monovalent vaccines in pregnant women - Taiwan, November 2009-August 2010. PLoS ONE 2011, 6(8):e23049.
32. Munoz F.M., Greisinger A.J., Wehmanen O.A., Mouzoon M.E., Hoyle J.C., Smith F.A., et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2005, 192(4):1098-1106.
33. Tavares F., Nazareth I., Monegal J.S., Kolte I., Verstraeten T., Bauchau V. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine 2011, 29(37):6358-6365.
34. Heikkinen T., Young J., van Beek E., Franke H., Verstraeten T., Weil J.G., et al. Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol 2012, 207(3):177.e1-177.e8.
35. Oppermann M., Fritzsche J., Weber-Schoendorfer C., Keller-Stanislawski B., Allignol A., Meister R., et al. A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine 2012, 30(30):4445-4452.
36. Conlin A.M., Bukowinski A.T., Sevick C.J., DeScisciolo C., Crum-Cianflone N.F. Safety of the pandemic H1N1 influenza vaccine among pregnant U.S. military women and their newborns. Obstet Gynecol 2013, 121(3):511-518.
37. Kallan B., Olausson P.O. Vaccination against H1N1 influenza with Pandemrix during pregnancy and delivery outcome: a Swedish register study. BJOG 2012, 119(13):1583-1590.
38. Kharbanda E.O., Vazquez-Benitez G., Lipkind H., Naleway A., Lee G., Nordin J.D., et al. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol 2013, 122(3):659-667.
39. Rubinstein F., Micone P., Bonotti A., Wainer V., Schwarcz A., Augustovski F., et al. Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study. BMJ 2013, 346:f393.
40. Thompson M., Williams J., Naleway A., Li D.K., Chu S., Bozeman S., et al. The Pregnancy and Influenza Project: design of an observational case-cohort study to evaluate influenza burden and vaccine effectiveness among pregnant women and their infants. Am J Obstet Gynecol 2011, 204(6 (Suppl. 1)):S69-S76.
41. Irving S.A., Kieke B.A., Donahue J.G., Mascola M.A., Baggs J., DeStefano F., et al. Trivalent inactivated influenza vaccine and spontaneous abortion. Obstet Gynecol 2013, 121(1):159-165.